The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases
Peter J Hotez, Miriam Alvarado, María-Gloria Basáñez, Ian Bolliger, Rupert Bourne, Michel Boussinesq, Simon J Brooker, Ami Shah Brown, Geoffrey Buckle, Christine M Budke, Hélène Carabin, Luc E Coffeng, Eric M Fèvre, Thomas Fürst, Yara A Halasa, Rashmi Jasrasaria, Nicole E Johns, Jennifer Keiser, Charles H King, Rafael Lozano, Michele E Murdoch, Simon O'Hanlon, Sebastien DS Pion, Rachel L Pullan, Kapa D Ramaiah, Thomas Roberts, Donald S Shepard, Jennifer L Smith, Wilma A Stolk, Eduardo A Undurraga, Juerg Utzinger, Mengru Wang, Christopher JL Murray, Mohsen Naghavi
2014-07-24
Abstract:The publication of the Global Burden of Disease Study 2010 (GBD 2010) and the accompanying collection of Lancet articles in December 2012 provided the most comprehensive attempt to quantify the burden of almost 300 diseases, injuries, and risk factors, including neglected tropical diseases (NTDs)[1–3]. The disability-adjusted life year (DALY), the metric used in the GBD 2010, is a tool which may be used to assess and compare the relative impact of a number of diseases locally and globally [4–6]. Table 1 lists the major NTDs as defined by the World Health Organization (WHO)[7] and their estimated DALYs [1]. With a few exceptions, most of the NTDs currently listed by the WHO [7] or those on the expanded list from PLOS Neglected Tropical Diseases [8] are disablers rather than killers, so the DALY estimates represent one of the few metrics available that could fully embrace the chronic effects of these infections. Even DALYs, however, do not tell the complete story of the harmful effects from NTDs. Some of the specific and potential shortcomings of GBD 2010 have been highlighted elsewhere [9]. Furthermore, DALYs measure only direct health loss and, for example, do not consider the economic impact of the NTDs that results from detrimental effects on school attendance and child development, agriculture (especially from zoonotic NTDs), and overall economic productivity [10, 11]. Nor do DALYs account for direct costs of treatment, surveillance, and prevention measures. Yet, economic impact has emerged as an essential feature of the NTDs, which may trap people in a cycle of poverty and disease [10–12]. Additional aspects not …